Traders bought shares of Alere Inc. (NYSE:ALR) on weakness during trading hours on Thursday. $31.49 million flowed into the stock on the tick-up and $6.68 million flowed out of the stock on the tick-down, for a money net flow of $24.81 million into the stock. Of all equities tracked, Alere had the 27th highest net in-flow for the day. Alere traded down ($0.04) for the day and closed at $50.11

ALR has been the topic of a number of recent analyst reports. Canaccord Genuity reissued a “buy” rating and set a $51.00 price target on shares of Alere in a research note on Monday, May 22nd. BTIG Research reissued a “hold” rating on shares of Alere in a research note on Wednesday, May 24th. Jefferies Group LLC reissued a “hold” rating and set a $51.00 price target on shares of Alere in a research note on Thursday, June 1st. Zacks Investment Research raised Alere from a “sell” rating to a “hold” rating in a research note on Tuesday, June 27th. Finally, BidaskClub lowered Alere from a “buy” rating to a “hold” rating in a research note on Sunday, July 16th. One research analyst has rated the stock with a sell rating and six have issued a hold rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $48.00.

The firm’s market cap is $4.39 billion. The firm has a 50-day moving average price of $49.65 and a 200 day moving average price of $47.02.

Several institutional investors have recently bought and sold shares of ALR. The Manufacturers Life Insurance Company grew its holdings in shares of Alere by 7.4% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 2,585 shares of the medical research company’s stock valued at $130,000 after acquiring an additional 179 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in shares of Alere by 11.6% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,094 shares of the medical research company’s stock valued at $155,000 after acquiring an additional 321 shares in the last quarter. Jane Street Group LLC grew its holdings in shares of Alere by 104.6% during the 1st quarter. Jane Street Group LLC now owns 5,090 shares of the medical research company’s stock valued at $202,000 after acquiring an additional 115,090 shares in the last quarter. Engineers Gate Manager LP purchased a new position in shares of Alere during the 1st quarter valued at $265,000. Finally, Prudential Financial Inc. grew its holdings in shares of Alere by 5.8% during the 2nd quarter. Prudential Financial Inc. now owns 5,515 shares of the medical research company’s stock valued at $277,000 after acquiring an additional 300 shares in the last quarter. Institutional investors and hedge funds own 88.76% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Investors Buy Shares of Alere Inc. (ALR) on Weakness” was originally published by Daily Political and is owned by of Daily Political. If you are viewing this story on another domain, it was stolen and reposted in violation of US & international copyright and trademark law. The legal version of this story can be read at https://www.dailypolitical.com/2017/09/14/investors-buy-shares-of-alere-inc-alr-on-weakness.html.

Alere Company Profile

Alere Inc is a provider of health information through diagnostic tests. The Company’s segments include professional diagnostics, consumer diagnostics, and corporate and other. The professional diagnostics segment includes an array of diagnostic test products and other in vitro diagnostic tests marketed to medical professionals and laboratories for detection of diseases and conditions within its areas of focus.

Receive News & Ratings for Alere Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alere Inc. and related companies with MarketBeat.com's FREE daily email newsletter.